Items with tag "infectious diseases"

News

Halving of new HIV infections by 2030 through better prevention

Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is no longer a death sentence. With the available tr…

Read more

Is a measles epidemic on its way?

In Wallonia, 70 persons got infected with measles. The World Health Organization (WHO) fears that the number of infections in Europe will increase. The disease was not occurring very frequentl…

Read more

Scientists isolate new antibodies to fight RSV

Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cau…

Read more

TiGenix Enrolls First Patient in Phase Ib/IIa Clinical Trial for Severe Sepsis

TiGenix, today announced that the first patient has been enrolled and treated in its Phase Ib/IIa clinical trial for Cx611 (SEPCELL) in the treatment of severe sepsis in community-acquired pneumon…

Read more

New insights in genetic defect allow prevention of fatal illnesses in children

A team of scientists led by prof. Adrian Liston (VIB–KU Leuven) and prof. Isabelle Meyts (UZ Leuven – KU Leuven) were able to characterize a new genetic immunodeficiency resulting from a mutation …

Read more

Survivors's plasma to treat ebola patients does not meet expectations

Ebola Tx is the largest clinical study ever performed with blood plasma of people that survived Ebola, to treat the disease. The study was performed in Guinea by the Institute of Tropical Medicine…

Read more

ABLYNX INITIATES PHASE IIb STUDY OF INHALED ANTI-RSV NANOBODY

ALX-0171 is a first-in-class inhaled Nanobody® developed for the treatment of RSV infections. The drug was found to be safe and well tolerated in a Phase IIa study in hospitalized infants with a R…

Read more

New treatment for urinary tract infections

Scientists from VIB-VUB discovered an important aspect in the development of urinary tract infections. Researchers from VIB and VUB joined hands with the US Center for Women's Infectious Disease R…

Read more

Belgian scientists discover missing link in septic shock

Researchers at VIB and Ghent University have discovered an important mechanism of sepsis, an overreaction of the body’s immune system to an infection. In this condition, the brain is unable to cur…

Read more

Quitting HIV treatment for the sake of science

With a temporary therapy stop, researchers from Ghent University and UZ Gent want to examine a new route to cure HIV. The research, led by Professor Linos Vandekerckhove, is unique in the world an…

Read more

Biocartis’ Ebola test approved for emergency use

The U.S. Food and Drug Administration (FDA) has granted Biocartis’ Ebola Virus Triage Test emergency use authorization. The test was developed in collaboration with Janssen Diagnostics and the Ins…

Read more

Japan pledges $130M to infectious disease fund

The Japanese government will invest an additional $130 million in the The Global Heath Innovative Technology (GHIT) Fund, which supports R&D on infectious diseases including malaria, tuberculosis,…

Read more

Hep C drug also active against zika

Scientists from KU Leuven have shown that the experimental antiviral drug 7DMA against hepatitis C slows down the development of the Zika virus in mice. The study, carried out by the Laboratory of…

Read more

Silencing the communication between bacteria increases their vulnerability

Treatment of an MRSA (Methicillin-resistant Staphylococcus aureus) infection often is very difficult, as these bacteria are resistant to many antibiotics. In addition, these bacteria often reside …

Read more

Zika-test will be ready soon

The Institute of Tropical Medicine (ITM) is working on a test to detect infection with the Zika virus. The test should be available in a few weeks. The Zika virus can now only be detected in a blo…

Read more

How Helicobacter clings on to our stomach

The bacterium Helicobacter pylori is a known gastric pathogen and causes the bulk of peptic ulcer and gastric cancer cases. H. pylori can survive in the hostile environment of the stomach by tight…

Read more

Belgian bioinformatics acquired by French pharma

Applied Maths, the Ghent-based developer of bioinformatic tools, has been acquired by BioMérieux. The software provided by Applied Maths facilitates the interpretation of complex biological data a…

Read more

Bill & Melinda Gates Foundation fund University of Antwerp’s polio research

Gates wants to eradicate polio with the help of UAntwerpen. In the Western world, polio is no longer existent since a couple of decades. However, it still makes victims in developing countries, al…

Read more

Urine HPV screening

HPV is the most common sexually transmitted infection (1). While most infections are subclinical, two virus serotypes are known to be carcinogenic. The lack of symptoms and the discomfort associat…

Read more

Roche acquires Biocartis’ competitor

Roche has paid 190 million dollar for the acquisition of GeneWEAVE (Los Gatos, CA), an American company that specializes in molecular diagnostics. GeneWEAVE’s shareholders even can receive 235 mil…

Read more

Insights

Battling antibiotic resistance: a new protein powered solution

Battling antibiotic resistance: a new protein powered solution

The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives were saved. But excessive antibiotic use in bot…

Read more

The biggest killer after malaria - How to tackle RSV?

The biggest killer after malaria - How to tackle RSV?

Respiratory syncytial virus (RSV) annually threatens many babies and there is currently no drug or vaccine to combat the disease. A lot of research and several clinical trials are ongoing. We spok…

Read more

WHO report ranks deadly diseases in need of drugs

WHO report ranks deadly diseases in need of drugs

The World Health Organization recently released a report outlining the imminent threat of antimicrobial-resistant diseases. In the midst of such doom and gloom, could a solution be found in our ow…

Read more

Watch out for Lyme disease!

Watch out for Lyme disease!

Summer is coming, it’s getting warmer, and you’re planning on outdoor activities. Unfortunately, ticks are getting out there as well, and your chances of being bitten are rising. Ticks can cause L…

Read more

Coris Bioconcept diagnoses antibiotic resistance

Coris Bioconcept diagnoses antibiotic resistance

With almost 20 years of experience, Coris BioConcept knows the world of infectious disease diagnostics inside and out. Their straightforward chromatography-based assays for pathogen detection, whi…

Read more

Colistin: breaking the last line of antibiotic defense

Colistin: breaking the last line of antibiotic defense

A first case of colistin resistance has been described in the US. This is troubling news, since colistin is used as a last-resort drug in combating infections with highly antibiotic-resistant bact…

Read more

Mosquitoes, the Zika virus and the threat for pregnant women: the buzz continues

Mosquitoes, the Zika virus and the threat for pregnant women: the buzz continues

Over the past months, the Zika virus has been spreading across Middle and South America. Zika has long been considered relatively harmless, but recently it was discovered that the virus could caus…

Read more

Tuberculosis - The Hidden Disease

Tuberculosis - The Hidden Disease

Pott’s disease, consumption, scrofula, white plague; tuberculosis (Tb), a disease almost as old as civilization itself, has had many names throughout history. Although a lot of progress has been m…

Read more

RSV OR THE FLU? NOW YOU KNOW IT IMMEDIATELY

RSV OR THE FLU? NOW YOU KNOW IT IMMEDIATELY

Janssen Diagnostics has developed a molecular diagnostic test which will be used with the Biocartis’ Idylla™ platform, to determine Influenza and Respiratory Syncytial Virus (RSV) infections of th…

Read more

A perspective of the future - Towards a cure for cancer and much more

A perspective of the future - Towards a cure for cancer and much more

‘Within 10 years we will be able to cure cancer’. A bold statement? Paul Stoffels (CSO J&J) doesn’t think so. He is a believer. He is also persistent, passionate, likes to be challenged and cha…

Read more

The Ebola Vaccine: a work in progress

The Ebola Vaccine: a work in progress

Maria Grazia Pau has more than 15 years of experience in vaccine research and is currently working at Janssen Vaccines (formerly Crucell) as a team leader in compound development.  Maria is workin…

Read more

Ebola diagnostics – faster, safer, and more accurate

Ebola diagnostics – faster, safer, and more accurate

“Last year the Ebola outbreak kick-started the development of a fast and accurate Ebola test to be used with Biocartis’ Idylla™ platform” - says Daap Kooij (Janssen Diagnostics). “We expect the te…

Read more

How to prevent Ebola's perfect storm?

How to prevent Ebola's perfect storm?

The 2014 Ebola outbreak was devastating. The virus affected 4 West African countries: Guinea, Liberia, Nigeria and Sierra Leone, killing some 10.000 people and infecting more than 25.000. Since 19…

Read more

VC Views

V-Bio feature: Mosquito Wars

V-Bio feature: Mosquito Wars

Mosquitoes are carriers of a range of crippling diseases, posing an enormous global health burden. Because current methods based on insecticides are inadequate, new tools are urgently needed. Wide…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Turnstone XpandInnovation GSK Janssen V-Bio Ventures KU Leuven Itera Life Science Flanders.bio UGent Biowin

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.